Exane Derivatives’s Lemonade LMND Stock Holding History
Bought
Maintained
Sold
Other funds holding LMND
GCGM
Exane Derivatives's LMND Position: Q2 2022 in Review
Exane Derivatives reduced its Lemonade (LMND) stake by 98% in Q2 2022, selling an estimated $86.9K and leaving 70 shares worth $1.28K. The position accounts for ﹤0.01% of the portfolio, ranked #480.
Exane Derivatives first reported a position in LMND in Q4 2021 and has held it in 3 quarters since. The position peaked at $197K in Q4 2021. 216 funds tracked by Wall St. Rank hold LMND as of Q2 2022.
- Exane Derivatives held 70 shares of Lemonade worth $1.28K as of Q2 2022.
- Exane Derivatives sold 4,125 Lemonade shares in Q2 2022, an estimated $86.9K.
- Lemonade made up ﹤0.01% of Exane Derivatives's portfolio in Q2 2022, its #480 holding.
- Exane Derivatives first reported a position in Lemonade in Q4 2021 and has held it in 3 quarters since.
- Exane Derivatives's Lemonade position peaked at $197K in Q4 2021.
- 216 funds tracked by Wall St. Rank held Lemonade as of Q2 2022.
Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.